Maiwald blog articles
New referral to the Enlarged Board of Appeal – continuation of the appeal by intervener – T1286/23
In the opposition appeal proceedings “T1286/23”, which we had already reported on “
Continue reading
Equivalent infringement in different European jurisdictions
As part of our regular internal legal seminars, Dr. Wilhelm Eger held a talk on current developments in infringement under the doctrine of equivalency in various European lega...
Continue reading
Implementation of the Pharmaceutical Strategy for Europe and the Intellectual Property Action Plan – Part 3
In addition to the pharmaceutical strategy for Europe[1], the European Commission adopted a new action plan for intellectual prop...
Continue reading
Implementation of the Pharmaceutical Strategy for Europe and the Intellectual Property Action Plan – Part 2
In addition to the Pharmaceutical strategy for Europe[1], the European Commission adopted a new Action Plan for Intellectual Prop...
Continue reading
Implementation of the Pharmaceutical Strategy for Europe and the Intellectual Property Action Plan – Part 1
Back in November 2020, the European Commission proposed a new Pharmaceutical Strategy for Europe which aims at ensuring the quality and safety of medicines while strengthening...
Continue reading
Revision of G3/04? – Discussion on the continuation of the appeal by intervener
In opposition appeal proceedings "T1286/23.3.2.04", Board 3.2.4 intends to deviate from decision G 3/04 and thus raises the prospect of a corresponding question being referred...
Continue reading
